BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Fibrosis
1
Immunoglobulin G4-related disease in the sigmoid colon in patient with severe colonic fibrosis and obstruction: A case report
10/25/2022 11:36:14 AM | Browse: 242 | Download: 507
2
Higher cardiovascular risk scores and liver fibrosis risk estimated by biomarkers in patients with metabolic-dysfunction-associated fatty liver disease
8/26/2022 9:51:35 AM | Browse: 251 | Download: 436
3
Use of shear wave elastography for the diagnosis and follow-up of biliary atresia: A meta-analysis
8/26/2022 7:50:06 AM | Browse: 224 | Download: 384
4
Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China
7/18/2022 9:47:46 AM | Browse: 336 | Download: 1312
5
Anabolic androgenic steroid-induced liver injury: An update
7/13/2022 7:30:59 AM | Browse: 289 | Download: 506
6
Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver disease
4/30/2022 5:08:22 AM | Browse: 304 | Download: 718
7
Application of artificial intelligence in non-alcoholic fatty liver disease and viral hepatitis
4/29/2022 11:12:04 AM | Browse: 369 | Download: 557
8
Loss of LAT1 sex-dependently delays recovery after caerulein-induced acute pancreatitis
3/11/2022 9:47:59 AM | Browse: 362 | Download: 673
9
Anti-fibrotic effect of adipose-derived stem cells on fibrotic scars
2/25/2022 12:19:16 PM | Browse: 352 | Download: 709
10
Correlation of hepatitis B surface antigen expression with clinicopathological and biochemical parameters in liver biopsies: A comprehensive study
1/21/2022 8:16:14 AM | Browse: 333 | Download: 649
11
Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter?
12/27/2021 5:24:00 AM | Browse: 275 | Download: 444
12
De novo and recurrence of metabolic dysfunction-associated fatty liver disease after liver transplantation
12/27/2021 5:24:00 AM | Browse: 334 | Download: 507
13
Multiparameter magnetic resonance imaging of liver fibrosis in a bile duct ligation mouse model
12/17/2021 8:56:01 AM | Browse: 451 | Download: 1013
14
Application of adipose-derived stem cells in treating fibrosis
11/25/2021 8:31:20 AM | Browse: 333 | Download: 517
15
Acetyl-CoA carboxylase inhibitors in non-alcoholic steatohepatitis: Is there a benefit?
10/20/2021 7:18:39 AM | Browse: 279 | Download: 380
16
Artificial intelligence for hepatitis evaluation
9/9/2021 6:46:56 AM | Browse: 477 | Download: 763
17
Non-alcoholic fatty liver disease in diabetes: When to refer to the hepatologist?
9/7/2021 8:15:21 AM | Browse: 481 | Download: 542
18
Clinical perspectives, assessment, and mechanisms of metabolic associated fatty liver disease in patients with COVID-19
9/3/2021 11:45:55 AM | Browse: 445 | Download: 671
19
Impact of donor-specific antibodies on long-term graft survival with pediatric liver transplantation
6/23/2021 1:49:40 AM | Browse: 594 | Download: 722
20
Noninvasive markers of liver steatosis and fibrosis after liver transplantation – Where do we stand?
3/18/2021 10:54:40 AM | Browse: 574 | Download: 781
21
Histopathological evaluation of long-term tenofovir disoproxil fumarate treatment in patients with hepatitis be antigen-negative chronic hepatitis B
3/18/2021 8:34:30 AM | Browse: 482 | Download: 936
22
Histopathology and predominantly progressive, indeterminate and predominately regressive score in hepatitis C virus patients after direct-acting antivirals therapy
1/29/2021 7:57:41 AM | Browse: 532 | Download: 1217
23
Autophagy in liver diseases
1/26/2021 4:22:54 PM | Browse: 518 | Download: 732
24
Obeticholic acid attenuates human immunodeficiency virus/alcohol metabolism-induced pro-fibrotic activation in liver cells
11/24/2020 12:41:21 PM | Browse: 559 | Download: 1273
25
Efficacy and safety of anti-hepatic fibrosis drugs
11/6/2020 7:36:12 AM | Browse: 633 | Download: 1287
26
Advances in the treatment of nonalcoholic steatohepatitis
10/29/2020 5:34:30 AM | Browse: 783 | Download: 1325
27
Periportal thickening on magnetic resonance imaging for hepatic fibrosis in infantile cholestasis
6/6/2020 2:43:56 PM | Browse: 851 | Download: 1394
28
Macrophages in metabolic associated fatty liver disease
4/28/2020 8:04:30 AM | Browse: 734 | Download: 970
29
Fibroblast growth factor signaling in non-alcoholic fatty liver disease and non-alcoholic steatohepatitis: Paving the way to hepatocellular carcinoma
1/16/2020 7:58:40 AM | Browse: 775 | Download: 1179
30
Inflammation and fibrosis in chronic liver diseases including non-alcoholic fatty liver disease and hepatitis C
1/13/2020 11:27:12 AM | Browse: 1004 | Download: 1220
31
Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source
9/7/2019 4:43:36 AM | Browse: 866 | Download: 1630
32
Layered enhancement at magnetic resonance enterography in inflammatory bowel disease: A meta-analysis
8/21/2019 9:19:18 AM | Browse: 918 | Download: 1485
33
Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease
7/28/2019 10:51:57 AM | Browse: 736 | Download: 840
34
Hepatocellular carcinoma: Therapeutic advances in signaling, epigenetic and immune targets
7/6/2019 6:23:58 AM | Browse: 1034 | Download: 1616
35
Roles of hepatic stellate cells in acute liver failure: From the perspective of inflammation and fibrosis
5/27/2019 8:24:36 AM | Browse: 797 | Download: 1256
36
Effectiveness of venous thromboembolism prophylaxis in patients with liver disease
4/26/2019 3:40:00 AM | Browse: 830 | Download: 1183
37
Repurposing drugs to target nonalcoholic steatohepatitis
4/18/2019 5:48:09 AM | Browse: 914 | Download: 1145
38
Persistent elevation of fibrosis biomarker cartilage oligomeric matrix protein following hepatitis C virus eradication
3/27/2019 10:37:20 AM | Browse: 1041 | Download: 1870
39
Diffusion-weighted magnetic resonance imaging and micro-RNA in the diagnosis of hepatic fibrosis in chronic hepatitis C virus
3/20/2019 5:32:10 AM | Browse: 1071 | Download: 1784
40
Noninvasive evaluation of nonalcoholic fatty liver disease: Current evidence and practice
3/20/2019 5:32:10 AM | Browse: 1018 | Download: 1183
41
Bariatric surgery in patients with non-alcoholic fatty liver disease - from pathophysiology to clinical effects
2/26/2019 11:29:04 AM | Browse: 987 | Download: 1298
42
Human immunodeficiency virus and hepatotropic viruses co-morbidities as the inducers of liver injury progression
1/26/2019 11:40:14 AM | Browse: 1209 | Download: 1228
43
Correlation analysis of collagen proportionate area in Budd-Chiari syndrome: A preliminary clinicopathological study
1/26/2019 8:24:19 AM | Browse: 797 | Download: 1255
44
Current status, problems, and perspectives of non-alcoholic fatty liver disease research
1/14/2019 2:54:12 PM | Browse: 1143 | Download: 1379
45
Role of cenicriviroc in the management of nonalcoholic fatty liver disease
12/27/2018 8:56:32 AM | Browse: 797 | Download: 983
46
Management of local recurrence after endoscopic resection of neoplastic colonic polyps
12/21/2018 6:09:14 AM | Browse: 883 | Download: 1234
47
Liver as a target of human immunodeficiency virus infection
11/13/2018 8:04:45 AM | Browse: 997 | Download: 1266
48
Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
10/18/2018 10:13:24 AM | Browse: 928 | Download: 1229
49
A small molecule fibrokinase inhibitor in a model of fibropolycystic hepatorenal disease
9/7/2018 9:21:44 AM | Browse: 955 | Download: 1440
50
Polycystic kidney and hepatic disease 1 gene mutations in von Meyenburg complexes: Case report
9/7/2018 1:56:18 AM | Browse: 840 | Download: 1187
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345